JY
MIRO

Jeff Yass’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Jeff Yass’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-19,739
Closed -$59K – 13849
2022
Q4 		$59K Buy
+19,739
New +$77.4K ﹤0.01% 11304

Other funds holding MIRO

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SFP
Sweet Financial Partners Fairmont, Minnesota $462M AUM 26.73% 1-Year Est. Return

Jeff Yass's MIRO Position: Q1 2023 in Review

Jeff Yass sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q1 2023, closing a stake of 19,739 shares — an estimated $59K sold.

Jeff Yass first reported a position in MIRO in Q4 2022 and held it in 1 quarter. The position peaked at $59K in Q4 2022. 31 funds tracked by Wall St. Rank hold MIRO as of Q1 2023.

  • Jeff Yass reported no remaining Miromatrix Medical Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jeff Yass sold 19,739 Miromatrix Medical Inc. Common Stock shares in Q1 2023, an estimated $59K.
  • Jeff Yass first reported a position in Miromatrix Medical Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Jeff Yass's Miromatrix Medical Inc. Common Stock position peaked at $59K in Q4 2022.
  • 31 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.